WHO ICTRP trial
To determine the half-maximal effective concentration (EC50) of ropivacaine for…
ChiCTR2300071319 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300071319 |
|---|---|
| Public title | To determine the half-maximal effective concentration (EC50) of ropivacaine for supra inguinal fascia iliaca compartment block (FICB) or pericapsular nerve group (PENG) block with lateral femoral cutaneous nerve block (LFCN) in the patient with total hip arthroplasty |
| Scientific title | To determine the half-maximal effective concentration (EC50) of ropivacaine for supra inguinal fascia iliaca compartment block (FICB) or pericapsular nerve group (PENG) block with lateral femoral cutaneous nerve block (LFCN) in the patient with total hip arthroplasty |
| Primary sponsor | Funing People's Hospital of Jiangsu Province |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Observation on analgesia of the patient with proximal femur fractures who accepted total hiparthroplasty |
| Interventions | pericapsular nerve group (PENG) block with lateral femoral cutaneous nerve block (LFCN) group:PENG block : various concentrations of ropivacaine with 20mL volume LFCN:LFCN : various concentrations of ropivacaine with 10mL volume; supra… |
| Registration date | May 11, 2023 |
| Target size | pericapsular nerve group (PENG) block with lateral femoral cutaneous nerve block… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: